Ecolab’s continued leadership position on renowned sustainability indices demonstrates the company’s record of advancing sustainable growth
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Receives registration of Valganciclovir powder for oral solution in Germany
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
The initiative will focus on advocating for cleaner air
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Subscribe To Our Newsletter & Stay Updated
